Danegaptide Hydrochloride
Danegaptide Hydrochloride (GAP-134) is a selective gap junction modifier. It has been investigated in preclinical research for its potential cardioprotective effects, particularly in models of cardiac arrhythmia and ischemia-reperfusion injury, in both in vitro and in vivo studies.
Product Specifications
CAS Number
943133-81-1
Product Name Alternative
Dipeptide, Danegaptide, Danegaptide Hydrochloride, Cardioprotective, antiarrhythmic, Inhibitor, Gap Junction Protein, GAP 134, Gap junction., GAP134, GAP-134, GAP-134 (Hydrochloride), GapJunctionProtein, orally, inhibit, ZP 1609, ZP 1609 Hydrochloride, ZP1609, ZP-1609, ZP1609 Hydrochloride, ZP-1609 Hydrochloride
Field of Research
Signal Transduction
Purity
99.55% (May vary between batches)
Solubility
DMSO:50 mg/mL (152.55 mM) ; H2O:50 mg/mL (152.55 mM)
Smiles
Cl.NCC (=O) N1C[C@@H] (C[C@H]1C (O) =O) NC (=O) c1ccccc1
Molecular Formula
C14H18ClN3O4
Molecular Weight
327.76
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
